You are here

  • Home
  • Archive
  • Volume 6, Issue 10
  • IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial

Citation Tools

Article menu

Download PDFPDF

XML
Cardiovascular medicine
Protocol
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Shantsila E, Haynes R, Calvert M, et al
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial
BMJ Open 2016;6:e012241. doi: 10.1136/bmjopen-2016-012241